Literature DB >> 27376448

Haploidentical transplantation with post-transplant cyclophosphamide following reduced-intensity conditioning for osteopetrosis: outcomes in three children.

T L Bahr1, T Lund2, N M Sando2, P J Orchard2, W P Miller2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27376448     DOI： 10.1038/bmt.2016.180

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Effect of weight and maturation on busulfan clearance in infants and small children undergoing hematopoietic cell transplantation.

Authors:  Radojka M Savic; Morton J Cowan; Christopher C Dvorak; Sung-Yun Pai; Luis Pereira; Imke H Bartelink; Jaap J Boelens; Robbert G M Bredius; Rob F Wynn; Geoff D E Cuvelier; Peter J Shaw; Mary A Slatter; Janel Long-Boyle
Journal:  Biol Blood Marrow Transplant       Date:  2013-09-09       Impact factor: 5.742

2.  Fludarabine and exposure-targeted busulfan compares favorably with busulfan/cyclophosphamide-based regimens in pediatric hematopoietic cell transplantation: maintaining efficacy with less toxicity.

Authors:  I H Bartelink; E M L van Reij; C E Gerhardt; E M van Maarseveen; A de Wildt; B Versluys; C A Lindemans; M B Bierings; Jaap Jan Boelens
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-04       Impact factor: 5.742

3.  Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study.

Authors:  I Esteves; C Bonfim; R Pasquini; V Funke; N F Pereira; V Rocha; Y Novis; C Arrais; V Colturato; M P de Souza; M Torres; J F Fernandes; F R Kerbauy; A A F Ribeiro; F P S Santos; N Hamerschlak
Journal:  Bone Marrow Transplant       Date:  2015-03-02       Impact factor: 5.483

4.  HLA-haploidentical blood progenitor cell transplantation in osteopetrosis.

Authors:  Ansgar S Schulz; Carl Friedrich Classen; Walther A Mihatsch; Michael Sigl-Kraetzig; Markus Wiesneth; Klaus-Michael Debatin; Wilhelm Friedrich; Susanna M Müller
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

5.  Hematopoietic stem cell transplantation for infantile osteopetrosis.

Authors:  Paul J Orchard; Anders L Fasth; Jennifer Le Rademacher; Wensheng He; Jaap Jan Boelens; Edwin M Horwitz; Amal Al-Seraihy; Mouhab Ayas; Carmem M Bonfim; Farid Boulad; Troy Lund; David K Buchbinder; Neena Kapoor; Tracey A O'Brien; Miguel A Diaz Perez; Paul A Veys; Mary Eapen
Journal:  Blood       Date:  2015-05-26       Impact factor: 22.113

6.  Severe pulmonary hypertension: a frequent complication of stem cell transplantation for malignant infantile osteopetrosis.

Authors:  C G Steward; I Pellier; A Mahajan; M T Ashworth; A G Stuart; A Fasth; D Lang; A Fischer; W Friedrich; A S Schulz
Journal:  Br J Haematol       Date:  2004-01       Impact factor: 6.998

Review 7.  Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation.

Authors:  Leo Luznik; Paul V O'Donnell; Ephraim J Fuchs
Journal:  Semin Oncol       Date:  2012-12       Impact factor: 4.929

8.  Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course.

Authors:  E J Gerritsen; J M Vossen; I H van Loo; J Hermans; M H Helfrich; C Griscelli; A Fischer
Journal:  Pediatrics       Date:  1994-02       Impact factor: 7.124

9.  Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report.

Authors:  G J A Driessen; E J A Gerritsen; A Fischer; A Fasth; W C J Hop; P Veys; F Porta; A Cant; C G Steward; J M Vossen; D Uckan; W Friedrich
Journal:  Bone Marrow Transplant       Date:  2003-10       Impact factor: 5.483

Review 10.  Comparable Outcomes for Hematologic Malignancies after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide and HLA-Matched Transplantation.

Authors:  Shannon R McCurdy; Ephraim J Fuchs
Journal:  Adv Hematol       Date:  2015-12-02
View more
  6 in total

Review 1.  T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant Disorders.

Authors:  Alice Bertaina; Angela Pitisci; Matilde Sinibaldi; Mattia Algeri
Journal:  Curr Hematol Malig Rep       Date:  2017-02       Impact factor: 3.952

Review 2.  Genetics of Osteopetrosis.

Authors:  Eleonora Palagano; Ciro Menale; Cristina Sobacchi; Anna Villa
Journal:  Curr Osteoporos Rep       Date:  2018-02       Impact factor: 5.096

3.  Generation of an immunodeficient mouse model of tcirg1-deficient autosomal recessive osteopetrosis.

Authors:  Eleonora Palagano; Sharon Muggeo; Laura Crisafulli; Irina L Tourkova; Dario Strina; Stefano Mantero; Elena Fontana; Silvia L Locatelli; Marta Monari; Emanuela Morenghi; Carmelo Carlo-Stella; John B Barnett; Harry C Blair; Paolo Vezzoni; Anna Villa; Cristina Sobacchi; Francesca Ficara
Journal:  Bone Rep       Date:  2020-01-07

Review 4.  Assessing the Efficacy of Alkylating Agent Regimens in the Treatment of Infantile Malignant Osteopetrosis: Cyclophosphamide, Busulfan, or Thiotepa.

Authors:  Himanshu Wagh; Amber Arif; Akshay J Reddy; Ethan Tabaie; Aditya Shekhar; Mildred Min; Neel Nawathey; Mark Bachir; Hetal Brahmbhatt
Journal:  Cureus       Date:  2022-07-06

5.  Haploidentical haematopoietic stem cell transplantation for malignant infantile osteopetrosis and intermediate osteopetrosis: a retrospective analysis of a single centre.

Authors:  Guanghua Zhu; Ang Wei; Bin Wang; Jun Yang; Yan Yan; Kai Wang; Chenguang Jia; Yanhui Luo; Sidan Li; Xuan Zhou; Tianyou Wang; Huyong Zheng; Maoquan Qin
Journal:  Orphanet J Rare Dis       Date:  2021-07-15       Impact factor: 4.123

6.  Haploidentical Hematopoietic Cell Transplantation Using Post-transplant Cyclophosphamide for Children with Non-malignant Diseases.

Authors:  Hasan Hashem; Rula Najjar; Mayada Abu-Shanap; Eman Khattab; Rawad Rihani; Abdelghani Tbakhi; Iyad Sultan
Journal:  J Clin Immunol       Date:  2021-08-06       Impact factor: 8.317
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.